Literature DB >> 8903346

Mutations of the two-nucleotide bulge of D5 of a group II intron block splicing in vitro and in vivo: phenotypes and suppressor mutations.

U Schmidt1, M Podar, U Stahl, P S Perlman.   

Abstract

Domain 5 (D5) is a highly conserved substructure of group II introns that is essential for catalysis of both steps of the splicing pathway. Here we studied the effects of mutations of the conserved 2-nt bulge in the binding and catalytic functions of D5 of intron aI5gamma of yeast mitochondrial DNA. Sequence variants of the 2-nt bulge reduced the rate of self-splicing somewhat. Deletion of one or both bulge nucleotides inhibited splicing more than 10(4)-fold, whereas mutants with a 3-nt bulge were much less debilitated. A novel allele with a symmetrical internal loop in place of the bulge self-splices nearly as actively as the control. Trans-splicing assays of D5 function showed some mutations primarily affect the catalytic function of D5, whereas others chiefly affect its binding function. Representative alleles were transformed into mtDNA and each inhibited splicing and respiratory growth. Pseudo-revertants included suppressor mutations nearby in D5 and one mutant yielded a dominant nuclear suppressor. These experiments provide new evidence that the D5 bulge is crucial for D5 binding and catalysis. It is possible that the bulge bends the D5 helix and that the extent of bending is especially important for D5 binding. The presence and exact nature of the bulge is also likely to have local structural consequences (besides bending) that influence the participation of specific backbone groups in binding and catalysis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8903346      PMCID: PMC1369445     

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  21 in total

1.  Selective forces for the origin of spliceosomes.

Authors:  Matej Vesteg; Zuzana Sándorová; Juraj Krajčovič
Journal:  J Mol Evol       Date:  2012-03-11       Impact factor: 2.395

Review 2.  The falsifiability of the models for the origin of eukaryotes.

Authors:  Matej Vesteg; Juraj Krajčovič
Journal:  Curr Genet       Date:  2011-10-19       Impact factor: 3.886

Review 3.  The tertiary structure of group II introns: implications for biological function and evolution.

Authors:  Anna Marie Pyle
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-06       Impact factor: 8.250

4.  Non-nearest-neighbor dependence of the stability for RNA group II single-nucleotide bulge loops.

Authors:  Michael D McCann; Geoffery F S Lim; Michelle L Manni; Julie Estes; Kelly A Klapec; Gregory D Frattini; Robert J Knarr; Jessica L Gratton; Martin J Serra
Journal:  RNA       Date:  2010-11-18       Impact factor: 4.942

5.  Three essential and conserved regions of the group II intron are proximal to the 5'-splice site.

Authors:  Alexandre de Lencastre; Anna Marie Pyle
Journal:  RNA       Date:  2007-11-26       Impact factor: 4.942

6.  A glimpse into the active site of a group II intron and maybe the spliceosome, too.

Authors:  Kwaku T Dayie; Richard A Padgett
Journal:  RNA       Date:  2008-07-24       Impact factor: 4.942

7.  Crystal structure of a self-spliced group II intron.

Authors:  Navtej Toor; Kevin S Keating; Sean D Taylor; Anna Marie Pyle
Journal:  Science       Date:  2008-04-04       Impact factor: 47.728

8.  A dynamic bulge in the U6 RNA internal stem-loop functions in spliceosome assembly and activation.

Authors:  C Joel McManus; Matthew L Schwartz; Samuel E Butcher; David A Brow
Journal:  RNA       Date:  2007-10-09       Impact factor: 4.942

9.  Enhanced group II intron retrohoming in magnesium-deficient Escherichia coli via selection of mutations in the ribozyme core.

Authors:  David M Truong; David J Sidote; Rick Russell; Alan M Lambowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

Review 10.  Structural insights into RNA splicing.

Authors:  Navtej Toor; Kevin S Keating; Anna Marie Pyle
Journal:  Curr Opin Struct Biol       Date:  2009-05-13       Impact factor: 6.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.